A detailed history of Martin Worley Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Martin Worley Group holds 406 shares of LLY stock, worth $380,600. This represents 0.17% of its overall portfolio holdings.

Number of Shares
406
Holding current value
$380,600
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$713.71 - $898.95 $289,766 - $364,973
406 New
406 $316,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $891B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Martin Worley Group Portfolio

Follow Martin Worley Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Worley Group, based on Form 13F filings with the SEC.

News

Stay updated on Martin Worley Group with notifications on news.